Literature DB >> 8418250

Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.

D J Hnatowich1, G Mardirossian, M Rusckowski, M Fogarasi, F Virzi, P Winnard.   

Abstract

To investigate the in vivo and in vitro properties of 99mTc when labeled to antibodies via one direct and one indirect method, the B72.3 and C110 IgG antibodies were radiolabeled directly via stannous ion reduction and indirectly via the hydrazino nicotinamide chelator and compared in vitro and in vivo. Antibody avidity (but not immunoreactive fraction) appeared to be independent of labeling methods for both antibodies. Following stannous ion reduction, antibodies were fragmented by denaturing SDS PAGE although only slight evidence of fragmentation was found in vivo. The direct label was instable to transchelation to cysteine and glutathione in vitro and in vivo. Following intravenous administration, urinary excretion of activity was threefold greater for the direct label and was almost exclusively labeled cysteine and glutathione. Significant differences in the biodistribution of 99mTc were also observed: liver levels were lower, kidney levels were higher and clearance of label from blood and tissues was faster for the direct label. At Day 1, tumor accumulation was threefold lower for the direct label although most normal tissues were also lower. In conclusion, when labeled to two antibodies by one direct method, 99mTc is unstable towards transchelation relative to one indirect method. These relative instabilities greatly influenced the biodistributions in mice and may influence the quality of images obtained in patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418250

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  6 in total

1.  Direct technetium-99m labeling of anti-hepatoma monoclonal antibody fragment:a radioimmunoconjugate for hepatocellular carcinoma imaging.

Authors:  Hui-Jie Bian; Zhi-Nan Chen; Jing-Lan Deng
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways.

Authors:  Zhonglin Liu; Leonie Wyffels; Christy Barber; Li Wan; Hua Xu; Mizhou M Hui; Lars R Furenlid; James M Woolfenden
Journal:  Nucl Med Biol       Date:  2012-06-28       Impact factor: 2.408

3.  Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.

Authors:  Chao Lou; Zhi-Nan Chen; Hui-Jie Bian; Jie Li; Shou-Bo Zhou
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

4.  Tc-99m ciprofloxacin imaging in acute cholecystitis.

Authors:  Yun-Mee Choe; Wonsick Choe; Keon-Young Lee; Seung-Ik Ahn; Kwang Kim; Young Up Cho; Sun Keun Choi; Yoon-Seok Hur; Sei-Joong Kim; Kee-Chun Hong; Seok-Hwan Shin; Kyung-Rae Kim; Ze-Hong Woo
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

5.  Development and evaluation of a novel (99m)tc-labeled annexin A5 for early detection of response to chemotherapy.

Authors:  Kazuma Ogawa; Katsuichi Ohtsuki; Tomomi Shibata; Miho Aoki; Morio Nakayama; Yoji Kitamura; Masahiro Ono; Masashi Ueda; Tomoki Doue; Masahisa Onoguchi; Kazuhiro Shiba; Akira Odani
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

6.  Non-invasive molecular imaging of inflammatory macrophages in allograft rejection.

Authors:  Alexander S G O'Neill; Samantha Y A Terry; Kathryn Brown; Lucy Meader; Andrew M S Wong; Jonathan D Cooper; Paul R Crocker; Wilson Wong; Gregory E D Mullen
Journal:  EJNMMI Res       Date:  2015-11-26       Impact factor: 3.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.